Using a transcriptome dataset for 51 breast cancer cell lines including luminal, ERBB2-amplified, basal and claudin-low lines [61], we determined whether expression of CA12 is also associated with that of ESR1 (Figure 3A) and how it compares with PGR expression (Figure 3B). This evidence concerns the gene ESR1 and breast carcinoma.